NPs appear to play a key role in this pathway, with potentially important implications, especially in patients with obesity and hypertension, in which NPs could be able to regulate not only the blood pressure, but also the LDLR levels, preventing PCSK9 overexpression. The gene discussed is PCSK9; the disease is obesity due to melanocortin 4 receptor deficiency.